Drug-resistant Tuberculosis
| Autor: | Rumi McGloin, Tobias R. Kollmann, Kelsey Inrig, Keswadee Lapphra, H. Simon Schaaf, Mona Al-Dabbagh, Laura Sauve, Ben J. Marais, Ian Kitai |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
Microbiology (medical)
Pediatrics medicine.medical_specialty Tuberculosis Adolescent Antitubercular Agents Terizidone Mycobacterium tuberculosis Tuberculosis Multidrug-Resistant medicine Humans Child Ethambutol biology business.industry Infant Newborn Infant Extensively drug-resistant tuberculosis Pyrazinamide biology.organism_classification medicine.disease Hearing disorder Infectious Diseases Child Preschool Pediatrics Perinatology and Child Health Immunology Drug Therapy Combination Ethionamide business medicine.drug |
| Zdroj: | Pediatric Infectious Disease Journal. 30:501-505 |
| ISSN: | 0891-3668 |
| DOI: | 10.1097/inf.0b013e31820b583d |
| Popis: | Drug-resistant Mycobacterium tuberculosis (TB) infection represents a serious and growing problem. For patients infected or suspected of being infected with multidrug or extensively drug-resistant TB, several medications have to be given simultaneously for prolonged periods. Here, we review the literature on treatment and monitoring of adverse effects of pediatric drug-resistant TB therapy in a high resource, low TB burden setting. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|